The European Investment Bank (EIB) is the ‘lending arm’ of the European Union. It is the world’s largest multilateral lender and the biggest provider of climate finance. The EIB Group Climate Bank Roadmap 2021-2025 outlines the goals for climate finance for supporting the European Green Deal. The EIB Group has two parts: the European Investment Bank and the European Investment Fund (EIF) that specialises in finance for small businesses and mid-caps.
The EIB contributes to the circular economy by providing financing, advisory support and knowledge sharing.
EIB provides finance to circular economy projects/promoters, also those with a higher risk profile.
The EIB in the circular economy
The transition towards a circular economy can help reduce climate change and environmental impact, but also bring major economic benefits, contributing to innovation, growth and job creation. The EU bank embraces the potential of a circular economy and supports the public and private sector in their circular transition.
EIB supports promoters with advisory
Advisory Hub and InnovFin Advisory support to circular economy projects
EIB experts deployed by the Advisory Hub and InnovFin Advisory provide tailored financial and technical advice for circular economy projects, which may later be financed by EIB or other partner financial institutions.
EIB is also active in circular economy knowledge sharing and awareness building.
InnovFin—EU finance for innovators
InnovFin financing tools cover a wide range of loans, guarantees and equity-type funding, which can be tailored to innovators’ needs. Financing is either provided directly or via a financial intermediary, most usually a bank or a fund.
European Investment Fund (EIF)
The EIF supports micro, small and medium sized enterprises (SMEs) by working with a wide range of funds, banks, guarantee and microfinance institutions across Europe.
The European Circular Bioeconomy Fund (EBCF)
The EEBCF is the first venture fund exclusively focused on the bioeconomy and circular bioeconomy. With a target of EUR 250m, to which the European investment bank has commited EUR 100 m, the EBCF is an important financial instrument. The investment focus is scaling up innovative bio-based companies in a late-stage (demonstration or commercial phases).